Chemfab Alkalis share price today

Chemfab Alkalis Ltd's share price was ₹302.05 at the close on 3 November 2026. It has been falling for 80 weeks. That is 27.9% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹291 and ₹556, and at that close it sat 4% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Chemfab Alkalis Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 7 weeks running.

Over the last 8.5 years the share price moved +34% while the NIFTY 500 moved +132%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 25 September 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

For April to June 2026 (the quarter ended 30 June 2026), Chemfab Alkalis reported revenue of ₹73.2 crore, down 20.1% from ₹91.5 crore a year earlier, and a profit of ₹5.73 crore, up 124.7% from ₹2.55 crore.

Chemfab Alkalis results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Chemfab Alkalis closed at ₹302.05 on 3 November 2026, down 50.4% from ₹608.85 a year earlier (31 October 2025) and up 75.6% over five years. Its highest weekly close since April 2018 was ₹1,132.85 on 1 November 2024.

Chemfab Alkalis share price: then and now

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

450 weekly closes from 27 April 2018 to 3 November 2026.

3 Nov 2026: Chemfab Alkalis closed at ₹302.05, up 2.6% on the week and down 8.0% on the month. 2 Sep 2026: ex-date for a dividend of ₹1.25 a share.

Earlier

• Results for April to June 2026: Revenue down 20.1% and profit up 124.7% on a year earlier.

Chemfab Alkalis paid ₹1.25 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.41% at the ₹302.05 close on 3 November 2026. The last was a dividend of ₹1.25 a share, ex-date 2 September 2026.

Chemfab Alkalis dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Not in its latest year. Chemfab Alkalis Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 4 of its last 7 reported years, so there is a history but no current dividend.

From the NSE corporate-actions record, read 4 November 2026.

Chemfab Alkalis is not on any of our India lists this week.

Chemfab Alkalis Ltd earned ₹5.7 Cr of net profit in the Jun 2026 quarter, +124.7% on the same quarter a year earlier. The full FY26 year was a loss of ₹3.0 Cr. That is 7.8% of the quarter's revenue. The same quarter a year earlier earned ₹2.5 Cr. 4 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

Chemfab Alkalis Ltd reported ₹73.2 Cr of revenue in the Jun 2026 quarter, −20.1% on the same quarter a year earlier. Over 6 years it has grown 7.2% a year on average. The last full year, FY26, came in at ₹311 Cr. The last four reported quarters add to ₹293 Cr.

Revenue is everything the company billed its customers in the period.

FY26 revenue was ₹311 Cr, −6.9% on the year before.

Recent pace: the last four quarters grew −16.0% on average, against 7.2% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew −16.2%, against −5.1% a year over the last 8 quarters (rolling over).

Chemfab Alkalis Ltd's operating margin was 13.8% in the Jun 2026 quarter, 1.5 percentage points higher than the same quarter a year ago. Across 7 years it has been between 9.0% and 33.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +1.5 percentage points on the year while gross margin changed −1.3 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 149% of Chemfab Alkalis Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹38.0 Cr of operating cash against −₹3.0 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹93.0 Cr of spending on assets, free cash was −₹55.0 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 149% of profit came in as cash: the cash cycle got 54 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: the bigger use of cash is spending on new assets, at 3.3× depreciation over three years. The next section checks what that spending is building.

Chemfab Alkalis Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 9 days in FY26, up from −45 days in FY21. It spent ₹281 Cr on assets over the last 3 years. Customers take 28 days to pay, and stock sits for 92 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹311 Cr, each day of that cycle ties up about ₹0.9 Cr, so roughly ₹8.0 Cr is tied up in the business at any time.

FY26: customers took 28 days to pay and stock sat for 92 days, about 3.0 months of sales sitting as stock, for a full cycle of 9 days, longer than FY21's −45.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 92 days. Customers pay about 28 days after that. Suppliers are paid at 111 days. Together that makes the 9-day cycle.

Spending on assets: ₹281 Cr over the last 3 years, against ₹86.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹31.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Chemfab Alkalis Ltd's P/E is 435.0×, near the high end of its own history: higher than 96% of past readings. Its usual P/E (the middle reading) is 13.9×, over 5.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

Where the price move came from: over 5 years the price moved +11.9% a year; about −40.5% a year came from earnings growth and about +52.4 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Chemfab Alkalis Ltd's business is getting worse. Revenue, profit and EPS growth are shrinking: revenue growth is −16.2% in the latest quarter, against +7.6% at its best in 12 quarters, with ROCE steady at 1.2%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Chemfab Alkalis Ltd earned a ROCE of 1% in FY26. Its return on capital used (ROIC) is 12.7 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −1.0% net margin and 0.54× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a −1.0% net margin × 0.54× asset turnover × 1.54× leverage (assets divided by equity) ≈ −0.8% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: −0.7% − 12.0% = −12.7 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

Chemfab Alkalis Ltd has total debt of ₹126 Cr against shareholder equity of ₹375 Cr as of Jun 2026, so its debt is 0.34× its equity. Year by year, that ratio went from 0.03 in FY22 to 0.34 in FY26. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

No group of Chemfab Alkalis Ltd's owners changed its stake by a full percentage point over the last two years. Foreign institutions moved −0.2 points over the same period, to 0.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Promoters: −0.7 points over 8 quarters, to 72.1%; Foreign institutions: −0.2 points over 8 quarters, to 0.0%; Domestic institutions: +0.0 points over 8 quarters, to 0.1%.

For Chemfab Alkalis Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

43.1 out of 100, rank 5 of 7 in Chemicals - Inorganic - Caustic Soda/Soda Ash, with 56% of the evidence available.

Chemfab Alkalis Ltd scores 43.1 out of 100 against the 7 companies it is compared with in Chemicals - Inorganic - Caustic Soda/Soda Ash, ranking 5. Some evidence is missing, so the score is pulled toward the middle on purpose.

The three scored parts add up to the total exactly: 25.8 + 4.8 + 12.5 = 43.1 (no relative-strength reading this week; its 20 points are shared across the other three). This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Chemfab Alkalis ranks 5 of 7 Chemicals - Inorganic - Caustic Soda/Soda Ash companies on the 4-Factor Sector Score, with 43.1 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Chemicals - Inorganic - Caustic Soda/Soda Ash, all 7 compared on one page.

Chemfab Alkalis is the 7th largest of 7 Chemicals - Inorganic - Caustic Soda/Soda Ash companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Tata Chemicals, Gujarat Alkalies & Chemicals, GHCL, TGV Sraac, Tuticorin Alkali Chemicals & Fertilizers and Primo Chemicals. It is the smallest.

Chemicals - Inorganic - Caustic Soda/Soda Ash companies close in size

1. Tata Chemicals Ltd ₹15,174 crore
2. Gujarat Alkalies & Chemicals Ltd ₹3,975 crore
3. GHCL Ltd ₹3,475 crore
4. TGV Sraac Ltd ₹1,171 crore
5. Tuticorin Alkali Chemicals & Fertilizers Ltd ₹579 crore
6. Primo Chemicals Ltd ₹548 crore
7. Chemfab Alkalis Ltd ₹472 crore

All 7 Chemicals - Inorganic - Caustic Soda/Soda Ash companies, largest first

Companies close in size in other industries

2085. W S Industries (India) Ltd ₹474 crore · General - Electric Equipement
2086. HLV Ltd ₹473 crore · Hotels
2087. Chemfab Alkalis Ltd ₹472 crore
2088. Credo Brands Marketing Ltd ₹472 crore · Textiles - Readymade Apparel
2089. Dhabriya Polywood Ltd ₹472 crore · Plastics - Others

Sector Alpha, written by code from the published numbers. Data as of 3 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.